A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ill COVID-19 patients by reducing life-threatening secondary infections.
Preliminary data from the CDC shows there were 627 deaths from COVID-19 in Washington last year, for a crude rate of 8 per ...
A new report reveals that acetaminophen, the world's most common pain medication, may lead users to engage in riskier ...
Moscow said there is "no evidence of a new or unidentified virus" as viral rumors spread on Russian social media.
The trial did not find remdesivir is deadly, and trials in COVID patients have found adverse effects are generally mild and rare. AAP FACTCHECK - Antiviral drug remdesivir was not found to be "toxic" ...
Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...
An unidentified virus has been reported in regions across Russia, with patients exhibiting persistent high fever and severe coughing, including the expectoration of blood. However, despite rising ...
New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say. The ...
Closure — if any such thing exists — is still out of reach for many pandemic survivors. The world has seemingly moved on even as so many people grieve.
March marks five years since the world shut down and announced a global pandemic. How has this changed us as a national and ...
Peter Marks, director of the agency’s Center for Biologics Evaluation and Research, was given the choice to resign or be ...
Health officials said they were concerned about the potential for measles to spread in B.C. as families return from overseas vacations in virus hotspots during spring break.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results